Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Reba

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
Biochemical and Biophysical Research Communications|September 16, 1991
Binding of radioiodinated SPECT ligands to transfected cell membranes expressing single muscarinic receptor subtypesB R Zeeberg, M S Gitler, J Baumgold, et al.
The American Journal of Physiology|March 1, 1993
Kinetic analysis of rat parotid gland muscarinic receptors in vivo: comparison with brain and heartY Hiramatsu, R Kawai, R C Reba, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1980
Radioiodinated estrogen derivativesJ K Mazaitis, R E Gibson, T Komai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
Nuclear medicine physician workforce requirements, Part 2: Benchmarking U.S. nuclear medicine physician workforce requirements based on managed care organization effects. Special Committee on ManpowerJ C Clouse, M Rogers, R C Reba, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1980
In vivo receptor binding of iodinated beta-adrenoceptor blockersW C Eckelman, R E Gibson, F Vieras, et al.
Brain Research|June 12, 1992
A novel m2-selective muscarinic antagonist: binding characteristics and autoradiographic distribution in rat brainM S Gitler, R C Reba, V I Cohen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1985
Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracerW C Eckelman, R Eng, W J Rzeszotarski, et al.
JAMA|December 6, 1985
Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomographyB L Holman, R E Gibson, T C Hill, et al.
Journal of Medicinal Chemistry|January 8, 1993
Synthesis and structure-activity relationship of some 5-[[[(dialkylamino)alkyl]-1-piperidinyl]acetyl]-10,11-dihydro-5H- benzo[b,e][1,4]diazepin-11-ones as M2-selective antimuscarinicsV I Cohen, J Baumgold, B Jin, et al.
American Journal of Obstetrics and Gynecology|April 1, 1997
In vitro and in vivo studies on the development of the alpha-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinomaJ Rotmensch, J L Whitlock, J L Schwartz, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
Biochemical and Biophysical Research Communications|September 16, 1991
Binding of radioiodinated SPECT ligands to transfected cell membranes expressing single muscarinic receptor subtypesB R Zeeberg, M S Gitler, J Baumgold, et al.
The American Journal of Physiology|March 1, 1993
Kinetic analysis of rat parotid gland muscarinic receptors in vivo: comparison with brain and heartY Hiramatsu, R Kawai, R C Reba, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1980
Radioiodinated estrogen derivativesJ K Mazaitis, R E Gibson, T Komai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
Nuclear medicine physician workforce requirements, Part 2: Benchmarking U.S. nuclear medicine physician workforce requirements based on managed care organization effects. Special Committee on ManpowerJ C Clouse, M Rogers, R C Reba, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1980
In vivo receptor binding of iodinated beta-adrenoceptor blockersW C Eckelman, R E Gibson, F Vieras, et al.
Brain Research|June 12, 1992
A novel m2-selective muscarinic antagonist: binding characteristics and autoradiographic distribution in rat brainM S Gitler, R C Reba, V I Cohen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1985
Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracerW C Eckelman, R Eng, W J Rzeszotarski, et al.
JAMA|December 6, 1985
Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomographyB L Holman, R E Gibson, T C Hill, et al.
Journal of Medicinal Chemistry|January 8, 1993
Synthesis and structure-activity relationship of some 5-[[[(dialkylamino)alkyl]-1-piperidinyl]acetyl]-10,11-dihydro-5H- benzo[b,e][1,4]diazepin-11-ones as M2-selective antimuscarinicsV I Cohen, J Baumgold, B Jin, et al.
American Journal of Obstetrics and Gynecology|April 1, 1997
In vitro and in vivo studies on the development of the alpha-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinomaJ Rotmensch, J L Whitlock, J L Schwartz, et al.
Pageof 17